HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. International Trade Commission (USITC) regarding supply chain challenges related to COVID-19 and critical medical products. HSCA appreciates the Commission’s leadership and efforts to-date to help identify COVID-related materials and goods and increase access to these essential supplies. Through collaboration and efforts to further strengthen supply chain resilience, we can best support our nation’s healthcare providers and overall preparedness. HSCA is committed to supporting patient care and ensuring healthcare providers are equipped to respond to emergencies and public health crises like the COVID-19 pandemic.
Click here to read the full comments.
Group Comment Letter to FDA on Clinical Immunogenicity Considerations from Biosimilar and Interchangeable Insulin Products
Dear Commissioner Hahn, The undersigned groups share the Food and Drug...
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...